If you or a loved one developed breast cancer, stomach cancer, bladder cancer, small
intestine cancer, colorectal cancer, kidney cancer, esophageal cancer, liver cancer, prostate cancer,
pancreatic cancer, leukemia, non-Hodgkin’s lymphoma, or multiple myeloma while taking Zantac® or another
ranitidine-containing medication, you may be eligible to file a lawsuit against the drug’s
Scientific studies have shown that when ranitidine — the active ingredient in Zantac — is metabolized in the body, it produces the cancer-causing substance NDMA. Consumers are now taking legal action against several drug companies for failing to warn consumers of this chemical link on the Zantac’s labeling.
Colon and rectal cancer
A class-action lawsuit against Zantac manufacturer, Sanoti-Aventis LLC, and former owner of the rights to Zantac, Boehringer Ingelheim, was filed 2019. The lawsuit alleges that the defendants failed to warn healthcare providers and the public about the dangers of taking Zantac by not revealing that it could produce NDMA in the human body.
If you or a loved one have sustained any of the injuries listed above after using Zantac or other generic ranitidine medicines, please fill out the form above so we can set you up with a lawyer in our network to discuss your situation so they can determine if you are eligible to join the Mass Tort lawsuit against negligent parties.